Asphyxiation versus ventricular fibrillation cardiac arrest in dogs. Differences in cerebral resuscitation effects - A preliminary study

Resuscitation

Volumn 35, Issue 1, 1997, Pages 41-52

  Vaagenes, Per ^a   Safar, Peter ^a   Moossy, John ^b   Rao, Gutti ^b   Diven, Warren ^b   Ravi, Chaitanya ^a   Arfors, Karl ^c  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^c Pharmacia ^*  (Sweden)

Author keywords

Asphyxia; Calcium blocker; Cardiopulmonary resuscitation; Cerebral ischemia; Free radical scavengers; Ventricular fibrillation

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; CREATINE KINASE; DEXTRAN; LIDOFLAZINE; MAGNESIUM SULFATE; MANNITOL; METHIONINE; SCAVENGER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASPHYXIA; BRAIN BLOOD FLOW; BRAIN FUNCTION; BRAIN ISCHEMIA; BRAIN REGION; CEREBROSPINAL FLUID; CONTROLLED STUDY; DOG; FEMALE; HEART ARREST; HEART VENTRICLE FIBRILLATION; INTENSIVE CARE; INTERMITTENT POSITIVE PRESSURE VENTILATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RESUSCITATION; TIME;

ANIMALS; ASPHYXIA; BRAIN ISCHEMIA; CALCIUM CHANNEL BLOCKERS; CARDIOPULMONARY RESUSCITATION; DOGS; FEMALE; FREE RADICAL SCAVENGERS; HEART ARREST; LIDOFLAZINE; MAGNESIUM SULFATE; MALE; POSITIVE-PRESSURE RESPIRATION; VENTRICULAR FIBRILLATION;

EID: 0030807149     PISSN: 03009572     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-9572(97)01108-8     Document Type: Article

References (53)

1. Safar P, Bircher NG. Cardiopulmonary Cerebral Resuscitation. An Introduction to Resuscitation Medicine. World Federation of Societies of Anesthesiologists. London: W.B. Saunders, 1988.
2. Safar P, Stezoski SW, Nemoto EM. Amelioration of brain damage after 12 min cardiac arrest in dogs. Arch Neurol 1976; 33: 91-95.
3. Sterz F, Leonov Y, Safar P, Radovsky A, Tisherman S, Oku K. Hypertension with or without hemodilution after cardiac arrest in dogs. Stroke 1990; 21: 1178-1184.
4. Leonov Y, Sterz F, Safar P, Johnson DW, Tisherman SA, Oku K-I. Hypertension with hemodilution prevents multifocal cerebral hypoperfusion after cardiac arrest in dogs. Stroke 1992; 23: 45-53.
5. Vaagenes P, Cantadore R, Safar P, Moossy J, Rao G, Diven W, Alexander H, Stezoski W. Amelioration of brain damage by lidoflazine after prolonged ventricular fibrillation cardiac arrest in dogs. Crit Care Med 1984; 12: 846-855.
6. Sterz F, Safar P, Tisherman S, Radovsky A, Kuboyama K, Oku K-I. Mild hypothermic cardiopulmonary resuscitation improves outcome after prolonged cardiac arrest in dogs. Crit Care Med 1991; 19: 379-389.
7. Negovsky VA, Gurvitch AM, Zolotokrylina ES. Postresuscitation Disease. Amsterdam: Elsevier, 1983.
8. Safar P. Prevention and therapy of postresuscitation neurologic dysfunction and injury. In: Paradis NA, Halperin HR, Nowak RM, editors. Cardiac Arrest. The Science and Practice of Resuscitation Medicine. Baltimore: Williams and Wilkins, 1996; 859-887.
9. Lind B, Snyder J, Safar P. Total brain ischaemia in dogs: cerebral physiological and metabolic changes after 15 minutes of circulatory arrest. Resuscitation 1975; 4: 97-113.
10. Snyder JV, Nemoto EM, Carroll RG, Safar P. Global ischemia in dogs: intracranial pressures, brain blood flow and metabolism. Stroke 1975; 6: 21-27.
11. Hossmann KA. Resuscitation potentials after prolonged global cerebral ischemia in cats. Crit Care Med 1988; 16: 964-971.
12. Sterz F, Leonov Y, Safar P, Johnson D, Oku K, Tisherman S, Latchaw R, Obrist W, Stezoski SW, Hecht S, Tarr R, Janosky JE. Multifocal cerebral blood flow by Xe-CT and global cerebral metabolism after prolonged cardiac arrest in dogs. Reperfusion with open-chest CPR or cardiopulmonary bypass. Resuscitation 1992; 24: 27-47.
13. Siesjo BK, Wieloch T. Cerebral metabolism in ischaemia: neurochemical basis for therapy. Br J Anaesth 1985; 57: 47-62.
14. McCord JM. Oxygen-derived free radicals in postischemic tissue injury. N Engl J Med 1985; 312: 159-163.
15. Ernster L. Biochemistry of reoxygenation injury. Crit Care Med 1988; 16: 947-953.
16. Safar P. Resuscitation from clinical death: Pathophysiologic limits and therapeutic potentials. Crit Care Med 1988; 16: 923-941.
17. Arfors KE, Hillered L. Oxygen radicals and biological injury. In: Wauquier A, Borger MM, Amery WK, editors. Protection of Tissues Against Hypoxia. Amsterdam: Elsevier, 1982; 223.
18. Safar P, Gisvold SE, Vaagenes P. Long-term animal models for the study of global brain ischemia. In: Wauquier A, Borgers M, Amery WK, editors. Protection of Tissues Against Hypoxia. Amsterdam: Elsevier, 1982; 147-170.
19. Safar P, Vaagenes P. Systematic search for brain resuscitation potentials after total circulatory arrest. In: Baethmann A, Go KG, Unterberg A, editors. Mechanisms of Secondary Brain Damage. NATO Symposium 1984. New York: Plenum Press, 1986; 349-375.
20. Safar P, Sterz F, Leonov Y, Radovsky A, Tisherman S, Oku K-I. Systematic development of cerebral resuscitation after cardiac arrest. Three promising treatments: cardiopulmonary bypass, hypertensive hemodilution, and mild hypothermia. Acta Neurochir 1993; 57: 110-121.
21. Vaagenes P, Safar P, Diven W, Moossy J, Rao G, Cantadore R, Kelsey S. Brain enzyme levels in CSF after cardiac arrest and resuscitation in dogs: markers of damage and predictors of outcome. J Cereb Blood Flow Metab 1988; 8: 262-275.
22. Vaagenes P, Safar P, Cantadore R, Cerchiari E, Diven W, Arfors K. Outcome trials of free radical scavengers and calcium entry blockers after cardiac arrest in two dog models (abstract). Ann Emerg Med 1986; 15: 665.
23. Vaagenes P, Safar P, Moossy J, Rao G, Diven W, Cantadore R. Differences in the effects of CNS treatments after ventricular fibrillation (VF) vs. asphyxiation (A) cardiac arrest (CA) in dog models (abstract). Crit Care Med 1988; 16: 447.
24. Vaagenes P, Safar P, Sharma C, Moossy J, Rao G, Diven W, Stezoski W. Differences of pathophysiology and therapeutic effects between asphyxial and ventricular fibrillation cardiac arrest in dogs (abstract). Resuscitation 1994; 28: S7.
25. Radovsky A, Safar P, Sterz F, Leonov Y, Reich H, Kuboyama K. Regional prevalence and distribution of ischemic neurons in dog brains 96 h after cardiac arrest of 0-20 min. Stroke 1995; 26: 2127-2314.
26. Safar P, Paradis NA. Asphyxial cardiac arrest. In: Paradis NA, Halperin HR, Nowak RM, editors. Cardiac Arrest. The Science and Practice of Resuscitation Medicine. Baltimore: Williams and Wilkins, 1996; 702-726.
27. Flameng W, Daenen W, Borgers M, Thone F, Xhonneux R, van de Water A, van Belle H. Cardioprotective effects of lidoflazine during 1 hour normothermic global ischemia. Circulation 1981; 64: 796-807.
28. Winegar CP, Henderson O, White BC, Jackson RE, O'Hara T, Krause GS, Vigor DN, Kontry R, Wilson W, Shelby-Lane C. Early amelioration of neurologic deficit by lidoflazine after fifteen minutes of cardiopulmonary arrest in dogs. Ann Emerg Med 1983; 12: 471-477.
29. Nemoto EM, Bleyaert AL, Stezoski SW, Moossy J, Rao GR, Safar P. Global brain ischemia: a reproducible monkey model. Stroke 1977; 8: 558-564.
30. Gisvold SE, Safar P, Rao G, Moossy J, Bron K, Alexander H. Prolonged immobilization and controlled ventilation do not improve outcome after global brain ischemia in monkeys. Crit Care Med 1984; 12: 171-179.
31. Cerchiari EL, Safar P, Klein E, Cantadore R, Pinsky M. Cardiovascular function and neurologic outcome after cardiac arrest in dogs. The cardiovascular post-resuscitation syndrome. Resuscitation 1993; 25: 9-33.
32. Rehncrona S. Brain acidosis. Ann Emerg Med 1985; 14: 770-776.
33. Meldrum B, Evans M, Griffith ST, Simon R. Ischemic brain damage: the role of excitatory activity and of calcium entry. Br J Anaesth 1985; 57: 44-46.
34. Kalimo H, Paljarvi L, Olsson Y, Siesjo BK. Structural aspects of energy failure states in the brain. In: Wiedmann K, Hoyer S, editors. Brain Protection. Morphological, Pathophysiological, and Clinical Aspects. Heidelberg: Springer-Verlag, 1983; 1-11.
35. Steen PA, Gisvold SE, Milde JH, Newberg LA, Scheithauer BW, Lanier WL, Michenfelder JD. Nimodipine improves outcome when given after complete cerebral ischemia in primates. Anesthesiology 1985; 62: 406-414.
36. Graham DI. The pathology of brain ischaemia and possibilities for therapeutic intervention. Br J Anaesth 1985; 57: 3-17.
37. Torvik A. The pathogenesis of watershed infarcts in the brain. Stroke 1984; 15: 221-223.
38. Brierley JB, Meldrum BS, Brown AW. The threshold and neuropathology of cerebral 'ischemic-anoxic' cell changes. Arch Neurol 1973; 29: 367-374.
39. Vaagenes P, Kjekshus J, Torvik A. The relationship between cerebrospinal fluid creatine kinase and morphologic changes in the brain after transient cardiac arrest. Circulation 1980; 61: 1194-1199.
40. Fleischer JE, Lanier WL, Milde JH, Michenfelder JD. Effect of lidoflazine on cerebral blood flow and neurologic outcome when administered after complete cerebral ischemia in dogs. Anesthesiology 1987; 66: 304-311.
41. Dean JM, Hoehner PJ, Rogers MC, Traystman RJ. Effect of lidoflazine on cerebral blood flow following 12 mins total cerebral ischemia. Stroke 1984; 15: 531-535.
42. Steen PA, Newberg LA, Milde JH, Michenfelder JD. Cerebral blood flow and neurologic outcome when nimodipine is given after complete cerebral ischemia in the dog. J Cereb Blood Flow Metab 1984; 4: 82-87.
43. Steen PA, Gisvold SE, Milde JH, et al. Nimodipine improves outcome when given after complete cerebral ischemia in primates. Anesthesiology 1985; 62: 406-414.
44. Abramson N, Safar P, Detre K, and the Brain Resuscitation Clinical Trial II Study Group. A randomized clinical study of a calcium-entry blocker (lidoflazine) in the treatment of comatose survivors of cardiac arrest. N Eng J Med 1991; 324: 1225-1231.
45. Abramson NS, Kelsey SF, Safar P, Sutton-Tyrrell K. Simpson's paradox and clinical trials: what you find is not necessarily what you prove. Ann Emerg Med 1992; 21: 1480-1482.
46. Bulkley GB. The role of oxygen free radicals in human disease processes. Surgery 1983; 94: 407-411.
47. Kompala SD, Babbs CF, Blaho KE. Effect of deferoxamine on late deaths following CPR in rats. Ann Emerg Med 1986; 15: 405-407.
48. Fleischer JE, Lanier WL, Milde JH, Michenfelder JD. Failure of deferoxamine, an iron chelator, to improve neurologic outcome following complete cerebral ischemia in dogs. Stroke 1987; 18: 124-127.
49. Kelly KJ, Badylak SF, Janas W, Grote LA, Babbs CF. Deferoxamine post-treatment following total cerebral ischemia in dogs (abstract 63). Ann Emerg Med 1987; 16: 494-495.
50. Cerchiari EL, Hoel TM, Safar P, Sclabassi RJ. Protective effects of combined superoxide dismutase and deferoxamine on recovery of cerebral blood flow and function after cardiac arrest in dogs. Stroke 1987; 18: 869-878.
51. Cerchiari EL, Sclabassi RJ, Safar P, Hoel TM. Effects of combined superoxide dismutase and deferoxamine on recovery of brainstem auditory evoked potentials and EEG after asphyxial cardiac arrest in dogs. Resuscitation 1990; 19: 25-40.
52. Reich H, Safar P, Angelos M, Basford R, Ernster L. Failure of a multifaceted anti-reoxygenation injury (RI) therapy to ameliorate brain damage after ventricular fibrillation (VF) cardiac arrest (CA) of 20 mins in dogs (abstract). Crit Care Med 1988; 16: 387.
53. Little JR. Modification of acute focal ischemia by treatment with mannitol. Stroke 1978; 9: 4-9.